Company Filing History:
Years Active: 2017
Title: Jaewoo Hong: Innovator in Immune System Modulation
Introduction
Jaewoo Hong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the modulation of the immune system. His innovative work has the potential to impact the treatment of diabetic patients.
Latest Patents
Jaewoo Hong holds a patent for the "Use of proinsulin for immune system modulation." This patent describes a composition aimed at promoting immune activity, which includes proteins such as dimeric proinsulin and C-peptide partially deleted mutants. The invention also outlines a composition for immunosuppression that utilizes the C-peptide site of proinsulin. These components can serve as immune enhancers for diabetic patients, showcasing the therapeutic potential of his research.
Career Highlights
Jaewoo Hong is affiliated with Konkuk University Industrial Cooperation Corporation, where he continues to advance his research and innovation. His work is characterized by a commitment to improving health outcomes through scientific discovery.
Collaborations
He collaborates with notable colleagues, including Soohyun Kim and Si-Young Lee, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jaewoo Hong's contributions to immune system modulation through his patent highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also holds promise for improving the lives of diabetic patients.